Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)

NCT04710199 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Virus Diseases

Interventions

DRUG: Maraviroc experimental group
OTHER: Standard treatment

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla